OptiBiotix continues to expand its presence in the microbiome health space after the recent listing of of its subsidiary ProBiotix Health on London’s Aquis Stock Exchange.
ProBiotix Health, a subsidiary of UK microbiome firm OptiBiotix Health announces a distribution deal with Cambridge Commodities (CCL) for its LPLDL ingredient and the dietary supplement CholBiomex3.